Seidu S, Avery L, Bell H, Brown P, Diggle J, Down S
Diabet Med. 2024; 42(3):e15500.
PMID: 39676327
PMC: 11823331.
DOI: 10.1111/dme.15500.
Alghadeer S, Mubarak A, Alsuwayni B, Almurdhi F, Almalki H, Alotaibi M
Saudi Pharm J. 2024; 32(10):102168.
PMID: 39295783
PMC: 11408277.
DOI: 10.1016/j.jsps.2024.102168.
Zhang S, Zhang X, Wang H, Fan W, Ma X, Song S
Front Endocrinol (Lausanne). 2024; 15:1368132.
PMID: 39036047
PMC: 11257838.
DOI: 10.3389/fendo.2024.1368132.
Wang W, Men L, Wang Y, Shi C, Yin H, Li H
Front Endocrinol (Lausanne). 2024; 15:1379830.
PMID: 38803476
PMC: 11129580.
DOI: 10.3389/fendo.2024.1379830.
Rosenstock J, Bajaj H, Lingvay I, Heller S
BMJ Open Diabetes Res Care. 2024; 12(3).
PMID: 38749508
PMC: 11097869.
DOI: 10.1136/bmjdrc-2023-003930.
Barriers to the Use of Insulin Therapy and Potential Solutions: A Narrative Review of Perspectives from the Asia-Pacific Region.
Chen R, Aamir A, Feroz Amin M, Bunnag P, Chan S, Guo L
Diabetes Ther. 2024; 15(6):1261-1277.
PMID: 38625535
PMC: 11096289.
DOI: 10.1007/s13300-024-01568-9.
Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients' Unmet Needs and Exploring Future Applications.
Ingrasciotta Y, Vitturi G, Trifiro G
J Clin Med. 2024; 13(7).
PMID: 38610878
PMC: 11012332.
DOI: 10.3390/jcm13072113.
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus.
Ajjan R, Battelino T, Cos X, Del Prato S, Philips J, Meyer L
Nat Rev Endocrinol. 2024; 20(7):426-440.
PMID: 38589493
DOI: 10.1038/s41574-024-00973-1.
Adherence and Persistence to Basal Insulin Among People with Type 2 Diabetes in Europe: A Systematic Literature Review and Meta-analysis.
Gimeno E, Bogelund M, Larsen S, Okkels A, Reitzel S, Ren H
Diabetes Ther. 2024; 15(5):1047-1067.
PMID: 38520604
PMC: 11043249.
DOI: 10.1007/s13300-024-01559-w.
Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Gonzalez J, Bebu I, Krause-Steinrauf H, Hoogendoorn C, Crespo-Ramos G, Presley C
Diabetes Care. 2024; 47(4):610-619.
PMID: 38416773
PMC: 10973899.
DOI: 10.2337/dc23-2459.
Therapeutic Inertia in the Management of Type 2 Diabetes: A Narrative Review.
Rodriguez P, San Martin V, Pantalone K
Diabetes Ther. 2024; 15(3):567-583.
PMID: 38272993
PMC: 10942954.
DOI: 10.1007/s13300-024-01530-9.
Perception and attitude of type 2 diabetic patients toward insulin therapy in the primary care of National Guard for Health Affairs (NGHA) in Jeddah, Saudi Arabia.
Alzahrani A, Alshareef R, Balubaid M, Alzahrani M, Alsoubhi M, Shaheen M
J Family Med Prim Care. 2024; 12(11):2768-2773.
PMID: 38186793
PMC: 10771210.
DOI: 10.4103/jfmpc.jfmpc_2484_22.
Therapeutic Inertia and Delays in Insulin Intensification in Type 2 Diabetes: A Literature Review.
Gavin J, Abaniel R, Virdi N
Diabetes Spectr. 2023; 36(4):379-384.
PMID: 38024219
PMC: 10654128.
DOI: 10.2337/ds22-0084.
The Use of Rescue Insulin in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Hollander P, Krause-Steinrauf H, Butera N, Kazemi E, Ahmann A, Fattaleh B
Diabetes Care. 2023; 47(4):638-645.
PMID: 37756542
PMC: 10973913.
DOI: 10.2337/dc23-0516.
The psychometric properties of the barriers to insulin treatment questionnaire in Chinese patients with type 2 diabetes mellitus using insulin.
Ma M, Ma X, Chang J, Yin F, Ma S, Zhang Y
Front Endocrinol (Lausanne). 2023; 14:1192108.
PMID: 37654567
PMC: 10465363.
DOI: 10.3389/fendo.2023.1192108.
Changes of health-related quality of life after initiating basal insulin treatment among people with type 2 diabetes.
Zhang P, Bao Y, Chen M, Zhang H, Zhu D, Ji L
Medicine (Baltimore). 2023; 102(34):e34718.
PMID: 37653806
PMC: 10470713.
DOI: 10.1097/MD.0000000000034718.
Myths and beliefs about insulin therapy in patients with diabetes mellitus and their family caregivers from a hospital in northern Peru, 2020.
Vera Ubillus J, Loayza Enriquez B, Guarniz Lozano R, Leon Jimenez F
Rev Peru Med Exp Salud Publica. 2023; 40(1):42-50.
PMID: 37377235
PMC: 10953673.
DOI: 10.17843/rpmesp.2023.401.12210.
Perceived Future Outcomes of Unsuccessful Treatment and Their Association with Treatment Persistence Among Type-2 Diabetes Patients: A Cross-Sectional Content Analysis.
Hidaka T, Suzuki R, Hashimoto K, Inoue M, Terada Y, Endo S
Diabetes Ther. 2023; 14(9):1437-1449.
PMID: 37340230
PMC: 10363091.
DOI: 10.1007/s13300-023-01433-1.
Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease.
Klupa T, Czupryniak L, Dzida G, Fichna P, Jarosz-Chobot P, Gumprecht J
Diabetes Ther. 2023; 14(8):1241-1266.
PMID: 37322319
PMC: 10299981.
DOI: 10.1007/s13300-023-01431-3.
The diabetes insulin self-management education (DIME) intervention for people with type 2 diabetes starting insulin: a pilot feasibility randomised controlled trial.
Winkley K, Sorsa T, Tian Q, Reece I, Fitzgerald C, Chamley M
Pilot Feasibility Stud. 2023; 9(1):89.
PMID: 37237318
PMC: 10213567.
DOI: 10.1186/s40814-023-01318-x.
